Redefining Tumor Suppression: AP-1 Transcription Factor M...

2026-01-20

Explore how the selective AP-1 transcription factor inhibitor SR 11302 (from APExBIO) is transforming cancer research and translational oncology. This article integrates mechanistic insights, recent evidence, and strategic guidance for researchers seeking to modulate tumor promotion and microenvironment signaling, with a focus on competitive advantages and future directions.